Department of Chemistry "Ugo Schiff" and CSGI, Via della Lastruccia 3-13, 50019 Florence, Italy.
Int J Mol Sci. 2020 Jul 20;21(14):5116. doi: 10.3390/ijms21145116.
Lipid liquid crystalline mesophases, resulting from the self-assembly of polymorphic lipids in water, have been widely explored as biocompatible drug delivery systems. In this respect, non-lamellar structures are particularly attractive: they are characterized by complex 3D architectures, with the coexistence of hydrophobic and hydrophilic regions that can conveniently host drugs of different polarities. The fine tunability of the structural parameters is nontrivial, but of paramount relevance, in order to control the diffusive properties of encapsulated active principles and, ultimately, their pharmacokinetics and release. In this work, we investigate the reaction kinetics of p-nitrophenyl phosphate conversion into p-nitrophenol, catalysed by the enzyme Alkaline Phosphatase, upon alternative confinement of the substrate and of the enzyme into liquid crystalline mesophases of phytantriol/HO containing variable amounts of an additive, sucrose stearate, able to swell the mesophase. A structural investigation through Small-Angle X-ray Scattering, revealed the possibility to finely control the structure/size of the mesophases with the amount of the included additive. A UV-vis spectroscopy study highlighted that the enzymatic reaction kinetics could be controlled by tuning the structural parameters of the mesophase, opening new perspectives for the exploitation of non-lamellar mesophases for confinement and controlled release of therapeutics.
脂质液晶中间相,由多晶脂质在水中自组装而成,已被广泛探索作为生物相容性的药物传递系统。在这方面,非层状结构特别有吸引力:它们的特点是具有复杂的 3D 结构,同时存在疏水区和亲水区,可以方便地容纳不同极性的药物。结构参数的精细调节虽然并不简单,但至关重要,这是为了控制封装的活性物质的扩散性质,最终控制其药代动力学和释放。在这项工作中,我们研究了在替代限制底物和酶进入含有可变数量添加剂蔗糖硬脂酸酯的植物三醇/HO 的液晶中间相的情况下,酶碱性磷酸酶将对硝基苯磷酸盐转化为对硝基苯酚的反应动力学。通过小角 X 射线散射进行的结构研究表明,通过包含添加剂的量可以精细控制中间相的结构/尺寸。紫外可见光谱研究表明,通过调节中间相的结构参数可以控制酶反应动力学,为利用非层状中间相来限制和控制治疗药物的释放开辟了新的前景。